September 5, 2023
The new AutoFox™ System promises to deliver hands-free, high-throughput Hydroxyl Radical Protein Footprinting for sophisticated Higher Order Structural (HOS) analysis Caption: GenNext Unveils the First Fully Automated HRPF System. Half Moon Bay, CA – GenNext Technologies, Inc., provider of novel instrumentation, software, and services for structural biology announced the release of the AutoFox Protein Footprinting [...]
New Visum Palm™ AI-assisted handheld NIR analyser
September 5, 2023
IRIS Technology Solutions introduces the latest version of its Visum Palm™ portable NIR analyser to complement its Visum® range of real-time process analysers for industry. The new Visum Palm™ is a fully portable NIR spectrophotometer that allows real-time analysis of different substances, products or mixtures, without the need for traditional laboratory and sampling techniques, allowing [...]
September 5, 2023
The integration of state-of-art chemometrics capabilities on a Cloud-based platform simplifies the development and deployment of robust new applications to fleets of handheld analyzers Menlo Park-- Si-Ware Systems, a leading provider of integrated micro-spectroscopy solutions, and Eigenvector Research, a renowned provider of multivariate analysis and chemometrics software, announced their partnership integrating Solo software into the [...]
Laying of the foundation stone at Analytik Jena
September 5, 2023
"A broad foundation to develop further": Starting signal for the construction of the Analytik Jena Campus at the Jena Göschwitz site / Together with our parent company Endress+Hauser, we are investing approximately 45 million Euros Jena – On September 5, the foundation stone was laid for the new Analytik Jena Campus at the Jena-Göschwitz site. The [...]
Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore
September 4, 2023
Innovative collaboration aims to boost the nation’s role as a leading cell and gene therapy manufacturer and clinical services through enabling translational research and development SINGAPORE, Singapore -- Agilent Technologies Inc. (NYSE: A) recently signed a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS), to develop cell and gene therapy [...]
September 4, 2023
Shimadzu Corporation will release the Brevis GC-2050 gas chromatograph. This instrument provides both productivity improvements and space savings while maintaining a high level of basic functionality and expandability of optional products. While inheriting the basic functionality of the Nexis GC-2030, our top of the line model released in 2017, this model is approximately 35 % [...]
September 2, 2023
On September 2, 2023, Tecniplast, global leader in the design, production, and distribution of preclinical research products, successfully completed its acquisition of Labosystem S.r.l. (www.labosystem.com) and KW S.r.l. (www.kwkw.it), following its earlier acquisition of BioAir in 2021. These acquisitions have led to the formation of TECNILABO, a dedicated laboratory division. Bioair, KW and Labosystem are [...]
Grenova Appoints Richard Pellegrino as Chief Research and Development Officer
September 1, 2023
Grenova, Inc., a Virginia-based designer, manufacturer, and distributor of instruments and associated consumables for the life sciences industry, today announced the appointment of Richard Pellegrino as Chief Research and Development Officer. Pellegrino joins Grenova during a period of rapid growth as the company expands its award-winning team designed to make the life sciences industry environmentally friendly, cost effective, [...]
Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering
August 31, 2023
BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades [...]
August 31, 2023
SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a drug discovery agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) to discover and develop novel antibodies for the treatment of autoimmune diseases. [...]

